Key points are not available for this paper at this time.
This study presents an innovative approach to plasma catalysis by employing nonthermal plasma type gliding arc with various iron oxides -Fe(II), Fe(III) and Ferrate Fe(VI)- for the removal of tetracycline antibiotic (TC). The experimental results demonstrated significant improvements in degradation rates, with plasma-Fe(VI) achieving complete degradation after 15 min of treatment and the plasma-Fe(II) achieving 97.28% removal after 30 min. The effect of TC initial concentration and catalyst dose was investigated, revealing that lower TC concentration favored the degradation and shortened treatment times with even a minimum amount of catalyst doses enhancing degradation results. Higher total organic carbon (TOC) removal was achieved in the combination systems (83.01%; 82.07%; and 42.82% for plasma/Fe(VI); plasma/Fe(II); and plasma /Fe(III) respectively) compared to plasma alone barely achieved 25.67% of mineralization. Additionally, the study examined the role of various radical scavengers-targeting •OH, superoxide, and free electrons- in the degradation process. TC intermediates were also identified, degradation pathways were proposed, and the intermediates toxicity was assessed. This research contributes to a deeper understanding of organic compounds treatment using nonthermal plasma, combination with the ferrate process or other catalysts.
Ouzar et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: